Funding Multi-indication Medicines: A Scoping Review of Health Technology Assessment and Reimbursement Frameworks
Isaiah Luc, Mah Laka, Drew Carter, Tracy Merlin · 2025
Read Funding Multi-indication Medicines: A Scoping Review of Health Technology Assessment and Reimbursement Frameworks by Isaiah Luc, Mah Laka, Drew Carter, Tracy Merlin (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12924833.txt.
Description
Isaiah Luc, Mah Laka, Drew Carter, and Tracy Merlin wrote a 2025 review of how health systems fund drugs that treat more than one illness. Judging each use apart can take years of repeated work and delay care for patients. Pricing is also hard, since a drug may be worth more for one illness than for another.
The team searched three large databases and the sites of review agencies for funding frameworks in rich countries. They found 16 frameworks, grouped into four kinds: policy, pricing, review methods, and choice making. Policy ideas included fast-track listing and joint review of all uses. Price ideas tied the price to each use. The review shows which parts of these frameworks could help systems with firm review rules already in place.
Catalog record
| CREATOR | Isaiah Luc, Mah Laka, Drew Carter, Tracy Merlin |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |